紫皮书

Overview

Purple Book, sometimes called 紫皮书, is a specialized online reference published by the U.S. Food and Drug Administration. It provIDEs structured Information about biological products that the FDA has licensed, with particular attention to biOSimilars and interchangeable biological products. In prACTice, it works as a searchable regulatory lookup rather than a general AI writing tool, useful for Professionals who need to verify product status, APProval pathways, and related detAIls.

The product name referenced here points to the FDA's public advanced-search interface, which means the experience is driven by government data and Standard Web Search functionality. This makes it a reliable first-stop resource for factual regulatory lookups, while the interpretation of that data remains the user's responsibility.

What it does

Purple Book lets users search a curated list of licensed biological products and view entries that describe the product's licensing status, the reference product it relates to, and whether interchangeability has been determined. It organizes infORMation that would otherwise be scattered across multiple FDA pages, giving researchers, phArmacists, and regulatory staff a single place to check bASIc facts.

The search interface supports filtering and keyword queries, which helps users nARRow results quickly. Because the directory is maintained by the FDA, entries may be updated as new biological products are licensed or as statuses change. Users should treat it as a reference index and confirm details with official labeling and primary regulatory documents.

Key capabilities

• Look up licensed biological products and their related reference products.
• Search and filter entries by product name and other available fields.
• Identify biosimilar and interchangeable product relationships where recorded.
• Review structured regulatory details such as licensing pathways.
• Access the resource through a standard web browser with no installation.

Who it is for

Purple Book is aimed at healthcare professionals, pharmacists, regulatory affairs specialists, researchers, and students who need reliable information about biological products. It is also useful for policy analysts and journalists seeking a starting point for understanding the U.S. biologics landscape. It is not intended for patients seeking Personal medical advice, and it should not replace CLInical judgment or official prescribing information.

How to get started

1. Open the FDA Purple Book advanced search page in a web browser.
2. Enter a product name or related term in the search field.
3. Apply available filters to narrow results by product type or status.
4. Select an entry to review its structured regulatory details.
5. Cross-check important findings against official labeling and FDA notices.

Pricing and access

The resource is a public government service and is Generally free to access from a web browser; no subscription is required. Availability, search fields, and data updates depend on the FDA and may change without notice. Users in some regions may encounter access restrictions, so connectivity may vary. Because details such as exact update timing and interface features can change, verify current information directly through official sources before relying on it for professional decisions.